Maximize efficacy and safety of approved drugs
Optimize the therapeutic benefit through patient-specific simulations (efficacy, toxicity) to reduce safety concerns, improve drug effectiveness, and increase a provider’s confidence level when administering the new therapy to patients.
Rapidly distribute companion apps at scale
Companion applications deploy seamlessly into clinical workflows, enabling scalable dosing support across providers. With a significant portion of approved drugs having FDA post-approval commitments, precision dosing combined with real-world data helps confirm dosing strategies in Phase IV and strengthen label optimization.
Create market differentiation with precision dosing
Strengthen your competitive advantage by offering companion apps tailored to specific drugs. Enhance brand loyalty by fostering an MSLs ability to engage providers in data-driven conversations, resulting in therapy enhancement and promoting better patient outcomes.
